Detalhe da pesquisa
1.
Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients.
Liver Int
; 42(12): 2674-2682, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152268
2.
Impact of the COVID-19 pandemic on patients with liver cirrhosis-the experience of a tertiary center in Germany.
Z Gastroenterol
; 59(9): 954-960, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34507374
3.
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg-Negative CHB.
Hepatol Commun
; 5(1): 97-111, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33437904
4.
Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy.
Open Forum Infect Dis
; 7(2): ofaa040, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32104719